SMMT
Asset Logo

SUMMIT THERAPEUTICS INC

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 230.39%
Annual Growth

5 years average annual growth

🌏

5
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.

πŸ“ˆ Performance

Price History*

+88.88%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$19.03

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in SMMT

5

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

24 weeks

πŸ’΅ Average investment amount

$411

⏰ Last time a customer invested in SMMT

12 days
SMMT investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

20%

26 - 34

60%

35 - 90

20%
πŸ™‹ Legal gender of investors

Female

80%

Male

20%

Pearlers who invest in SMMT also invest in...

NVIDIA Corporation

NVDA

πŸ™Œ Performance (5Yr p.a)

421.98%

πŸ“Š Share price

$137.71 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ“Š Share price

$71.77 USD

πŸ™Œ Performance (5Yr p.a)

33.12%

πŸ“Š Share price

$81.88 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

8.15%

πŸ“Š Share price

$42.28 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

6.83%

πŸ“Š Share price

$140.18 USD

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

3.33%

πŸ“Š Share price

$42.07 USD

πŸ™Œ Performance (5Yr p.a)

8.48%

πŸ“Š Share price

$69.97 USD

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist